Average Co-Inventor Count = 6.82
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (22 from 4,177 patents)
2. Abbvie Inc. (3 from 822 patents)
3. Abbvie Bahamas Limited (6 patents)
25 patents:
1. 8940778 - Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
2. 8642776 - Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
3. 8299243 - Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
4. 8273736 - Thienopyridine and furopyridine kinase inhibitors
5. 8063091 - Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
6. 7737160 - Thienopyridine and furopyridine kinase inhibitors
7. 7598283 - Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
8. 7560552 - Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
9. 7297709 - Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
10. 7202363 - Thienopyridine and furopyridine kinase inhibitors
11. 7129260 - Isoindolinone kinase inhibitors
12. 6294573 - Reverse hydroxamate inhibitors of matrix metalloproteinases
13. 6288261 - Inhibitors of matrix metalloproteinases
14. 6235786 - Reverse hydroxamate inhibitors of matrix metalloproteinases
15. 5985911 - C-terminal ketone inhibitors of matrix metalloproteinases and TNF.alpha.